AACE/ACE Focus on Lipids: 2017 Consensus Guidelines
The AACE/ACE 2017 recommendations on lipid management renew focus on LDL-C targets, and go far lower than any group has ventured to date.
Beta Blockers Heighten Risk of CV Events in T2DM
Post-hoc analysis of ACCORD trial data suggests the indication of beta blocker therapy in T2DM patients be more closely examined.
Home Use of Artificial Beta Cells
Artificial beta cell systems and insulin pumps went head-to-head in two trials with type 1 diabetes patients.
Metformin – what we didn’t know
A new study turns conventional beliefs about metformin’s main site of action upside down.
The Importance of Healthy Diets
Three new studies provide evidence to help convince your patients about the importance of healthy eating.
Neighborhood Access to Exercise Facilities and Healthy Food Resources Tied to Decreased T2DM
“In brief, the risk for T2DM is a combination of both person and place, and our national strategies need to understand and intervene across these levels.”